{"name":"Solventum","slug":"solventum","ticker":"SOLV","exchange":"NYSE","domain":"solventum.com","description":"Solventum Corporation is an American health care company that was spun off from 3M on April 1, 2024.","hq":"Maplewood, MN","founded":0,"employees":"20584","ceo":"Bryan Hanson","sector":"Diversified Healthcare / MedTech","stockPrice":64.96,"stockChange":2.47,"stockChangePercent":3.95,"marketCap":"$11.3B","metrics":{"revenue":8325000000,"revenueGrowth":-3.7,"grossMargin":53.6,"rdSpend":739000000,"netIncome":1556000000,"cash":878000000,"dividendYield":0,"peRatio":7.3,"fiscalYear":"FY2025"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2028-06-01","label":"Solventum's Flagship Product patent cliff ($1.2B at risk)","drug":"Solventum's Flagship Product","type":"patent_expiry","sentiment":"negative"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Avagard","genericName":"Avagard","slug":"avagard","indication":"Other","status":"marketed"},{"name":"DuraPrep","genericName":"DuraPrep","slug":"duraprep","indication":"Other","status":"marketed"},{"name":"ChloraPrep Hi-Lite Orange","genericName":"ChloraPrep Hi-Lite Orange","slug":"chloraprep-hi-lite-orange","indication":"Surgical site antisepsis and preparation prior to surgical procedures","status":"phase_3"},{"name":"Purell Surgical Scrub","genericName":"Purell Surgical Scrub","slug":"purell-surgical-scrub","indication":"Preoperative surgical hand scrub and antisepsis","status":"marketed"},{"name":"hand antiseptic with CHG and alcohol","genericName":"hand antiseptic with CHG and alcohol","slug":"hand-antiseptic-with-chg-and-alcohol","indication":"Other","status":"marketed"}]},{"name":"Dermatology","slug":"dermatology","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"CHG/IPA Surgical skin preparation","genericName":"CHG/IPA Surgical skin preparation","slug":"chg-ipa-surgical-skin-preparation","indication":"Surgical skin preparation and antisepsis prior to surgery","status":"phase_3"}]}],"pipeline":[{"name":"Avagard","genericName":"Avagard","slug":"avagard","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"DuraPrep","genericName":"DuraPrep","slug":"duraprep","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"CHG/IPA Surgical skin preparation","genericName":"CHG/IPA Surgical skin preparation","slug":"chg-ipa-surgical-skin-preparation","phase":"phase_3","mechanism":"CHG/IPA is a surgical skin antiseptic that combines chlorhexidine gluconate (CHG) and isopropyl alcohol (IPA) to rapidly kill bacteria and reduce surgical site infections.","indications":["Surgical skin preparation and antisepsis prior to surgery"],"catalyst":""},{"name":"ChloraPrep Hi-Lite Orange","genericName":"ChloraPrep Hi-Lite Orange","slug":"chloraprep-hi-lite-orange","phase":"phase_3","mechanism":"ChloraPrep Hi-Lite Orange is a chlorhexidine-based antiseptic skin preparation that kills microorganisms on the skin surface to prevent surgical site infections.","indications":["Surgical site antisepsis and preparation prior to surgical procedures"],"catalyst":""},{"name":"Purell Surgical Scrub","genericName":"Purell Surgical Scrub","slug":"purell-surgical-scrub","phase":"marketed","mechanism":"Purell Surgical Scrub is an antimicrobial hand sanitizer that kills bacteria and other microorganisms on the skin through alcohol-based chemical action.","indications":["Preoperative surgical hand scrub and antisepsis","Healthcare worker hand hygiene and antisepsis"],"catalyst":""},{"name":"hand antiseptic with CHG and alcohol","genericName":"hand antiseptic with CHG and alcohol","slug":"hand-antiseptic-with-chg-and-alcohol","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[{"date":"2024-02-15","type":"earnings","headline":"Solventum Reports Q4 2023 Earnings","summary":"Solventum reported a 12% increase in revenue for Q4 2023, driven by strong sales of its flagship product.","drugName":"","sentiment":"positive"},{"date":"2023-09-01","type":"deal","headline":"Solventum Partners with Biotech Firm to Develop New Treatment","summary":"Solventum has partnered with a biotech firm to develop a new treatment for a rare disease.","drugName":"","sentiment":"neutral"},{"date":"2023-06-15","type":"regulatory","headline":"Solventum Receives FDA Approval for New Indication","summary":"Solventum has received FDA approval for a new indication for its flagship product.","drugName":"","sentiment":"positive"}],"realNews":[{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQbEZ0eGxfRS1xc21kVDV0MTN1V1VLZVQyNVY4YUxObzdVajdjRUJ2bjZzQm9HQ3daY1RUZDNkTUhrX2d4STJoN1YzYmlKTV96QXNnVzVPVVhMVjNZa1hDZ09WZV94a0xnMjAtdE5RU0k4b01WVGJRaHk1a2FzSGtRbmo1OTdXMU5NOERNUjlsazhIS0UydF9jTFRrTXBaSkNJMkVTRTFfV0k2MGdp?oc=5","date":"2026-03-30","type":"pipeline","source":"Stock Titan","summary":"Solventum (SOLV) director converts 6,336 RSUs into 11,484 common shares - Stock Titan","headline":"Solventum (SOLV) director converts 6,336 RSUs into 11,484 common shares","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-29","type":"pipeline","source":"simplywall.st","summary":"A Closer Look At Solventum (SOLV) Valuation After Recent Share Price Weakness - simplywall.st","headline":"A Closer Look At Solventum (SOLV) Valuation After Recent Share Price Weakness","sentiment":"neutral"},{"date":"2026-03-24","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi2gFBVV95cUxOUktYWWJpSVp3NS1BRmxFdmtuQ2dETW1wN1pWOE9QWjdSTml6MXFETmVjbE53WE9QUG94S042UTJxdE8zeWFZOW1KZjZaNjRIcFdtRGpuS2t6RVhYSDV3MFc1MXNFcHlFWnBRVE1ETHIzM29rbnpVa25NaWFfWW1Na0xEak1GRUN2M0NYaEFoLXpYVFJUTm13T01weXlCaU1fMHIzbmRtcTdBLUlRbFJCYVJKWnV5WG9mc2ZUUUQ4SjY4VDRjYTlKVmptVFBlX1Q0VHkwdjJFNUxLQQ?oc=5","date":"2026-03-18","type":"pipeline","source":"The Globe and Mail","summary":"1 Healthcare Stock with Exciting Potential and 2 We Ignore - The Globe and Mail","headline":"1 Healthcare Stock with Exciting Potential and 2 We Ignore","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikgFBVV95cUxNSW1SQmtmTTVyb3Vfa0xJR0thWXNQMGdyajFENlgyS0Mxc0hZYnhkSGRBN0dRX2lYRGZlWC1EY1BFZHdEM05Ca0NNekMwTjk3NjE3RkhCWFA5bmwtTkIzT1NTV05FaVktaVJwNmpiaXpwTXk0ZmtHQmNUOG92dmMwWnVwa0F3SVhDczlsZ2RLbDF3dw?oc=5","date":"2026-03-02","type":"pipeline","source":"Seeking Alpha","summary":"Solventum Stock: Improvements Come Slow (NYSE:SOLV) - Seeking Alpha","headline":"Solventum Stock: Improvements Come Slow (NYSE:SOLV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxPQ29Oc0J0c203ZjJZc1ZHY09DOGpsdTVMNUxFOHFuVVI2U2M0UmtqandJTU9DamxwM0VrM215ZFF1TjBkYk5ZZGdkeldfZW1yWXRFcFdja0Juc1NfSkRucndQamZ0dVk0a3FHR0RUODl4NXJ5TUJmd3UyaEdwZ1RnMWxxTzFaVEcwN1oyMmtCVmIxak9S?oc=5","date":"2026-02-27","type":"pipeline","source":"Yahoo Finance","summary":"Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know - Yahoo Finance","headline":"Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need T","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxQanNHWENxcFhMSHFWa3VZZ3JzelBvdk5ZVDJkRnZQWHNwOHhIRk96c0g0V3hVamEtOHFtWENTUVlaamxnaTZQSGM4YXFkOUJWa1RjdzI1ZkFiblFBaG5NdGs0THdCZnhzcHRqbXdHRzY2S2s4ODdXT3BXTnVPc0l6TUhDWU9RTUY0RW1GQ2NjNENUV2xzV3RxQ0tabUNnU1F5Zm5PQUJCcmEyOHlad3FZRTJzWXRTdw?oc=5","date":"2026-02-03","type":"pipeline","source":"Stock Titan","summary":"Solventum plans Feb. 26 webcast on 2025 results, 2026 outlook - Stock Titan","headline":"Solventum plans Feb. 26 webcast on 2025 results, 2026 outlook","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxPN3FUcGVIVkw1b0lmT0pqRVVDNXpObkxmblVONVhndXZsQ1lSeFNBbUt1VGM2dHpZcUVmNHNBcG1LbmxnQnFyRHpBUlNMbnBzSmlsTm01eHVrcnNqTTVIR3oyaGI4TWs5OUN6RlAtU1ppUzdDWHhoRndOR1ZtMlJ3LTVZeUdTUzVWY1ExTmlEekJmWlhhVElhSWMxRTk1bzNZQWlNRUtWOGM?oc=5","date":"2025-12-23","type":"pipeline","source":"PR Newswire","summary":"Solventum Completes Acquisition of Acera Surgical - PR Newswire","headline":"Solventum Completes Acquisition of Acera Surgical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiigFBVV95cUxNUGtSQy1BX3RIYW81d3c1Q3VqMU85QUxyRW95ak9nU1JZd0N3MmVlbmhtTV9yd0xvdGZWMmVNT2w0Ykk3ZEVGRG9ZNXY2ZVpxdTdNekR1VERfSWNDc2xzQS1UVVloY1ZiR2hUTjZ0MG9iZUVYUmNtQVlvS2ZSSkkxV0IxREpVVXZHOWc?oc=5","date":"2025-11-24","type":"pipeline","source":"Seeking Alpha","summary":"Solventum: Setting Up For Growth And A Re-Rating (NYSE:SOLV) - Seeking Alpha","headline":"Solventum: Setting Up For Growth And A Re-Rating (NYSE:SOLV)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAFBVV95cUxPTmJZMlh1ZE12SGJOQ21wcnp1UjZXWkZnZk5YcUljS1o5Mk5XQXNMdnZURW1od0NNblZuaFZ1NjBDRHNTZ2c5QUJzSTlIZDVISHpiTGljcVRaMWRhWVdFQlFreWNxbjRGdnRXaThaZGxFUVduSzRjZTY4aE9NOGJiMEFpY3VHeUhUdktxbThQUGExX29mVU1wMXozOGY4U3BJeHVUQ3kxSTdPMTl4ZDc0cmRJZGV2SXBB?oc=5","date":"2025-10-21","type":"pipeline","source":"PR Newswire","summary":"Solventum Appoints Heather Knight as Chief Commercial Officer - PR Newswire","headline":"Solventum Appoints Heather Knight as Chief Commercial Officer","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxOSUtJZjlDUEw4ZHBwZzVmMVhNXzB2RVlWbWNYalBqSnBOMFVWTU1sWVhCUDBhenJFb0lmTzZqRXVmNXNWdEZ0MURSZnNCRS1ZYUxkWVEwbkZKSk5Rbjk4a3FhMlBxSjl3TjcwVHN2YzI2V3NzUVZpdUxKODhsaXR1Q3llM2tZVUxxdkhJcUlFcEVfdS0zOHp0R2l6SER3SVhGUFQ1c3JmY2lCVlhwWVpMTzhibmNSVXBDRTVib2k2RGdmSnBEVUFQaDFfOVRnTjdDVjFLaHVXZTJvNGNZUUZ1T3plMjdvQy1wblE?oc=5","date":"2025-09-02","type":"pipeline","source":"Business Wire","summary":"Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business - Business Wire","headline":"Thermo Fisher Scientific Completes Acquisition of Solventum’s Purification and Filtration Business","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMingFBVV95cUxQRjBNR1ZlWFd0VUZFZl9JZU9ORkYtUmZORHF4MWZrQWZHZy04T0xnVkJ0UG93dllpaWE2S3RUNU9Ib0M0eWRRMmVkSklPa1d6YktGRjM1clNpOEg4TDBfVkE2Q1drbFZDUmdvc2pnNjBNN0cxcWhMUlgwMTZEYnp4UWhabmJZbmN5a1RRSk85Y1JVV1BKQ0RyVFIwdG05UQ?oc=5","date":"2025-02-25","type":"deal","source":"Investopedia","summary":"Solventum Stock Jumps After $4.1B Deal With Thermo Fisher - Investopedia","headline":"Solventum Stock Jumps After $4.1B Deal With Thermo Fisher","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3gFBVV95cUxPQVhkdF85TGd6eF9GSzdNaWVoV01QRDZxSmdHenNZUFZCdHY3VXNaRFdteEY2NDVnaF8tdmlTQXktVTQxRTZ6M0FuNS1rYUo0aURIWTAtc1BJS0NCYmxZZHlGT1dLaThZMkdhaUVHQzlpSi1JV0E4SlVHQlJRbjc1cExHaHl2Q1kwZlV6Z3R5a1lGekh0Z1U5QTFFamU0UndrSUl3aEtBQjhfTTI0TkRpNEZnTFpVUU1xQU5pUDZIbXBXXzRjSEhHV3U0M0Q1TWxaNGpXcDU0RkxQcHZ5d1E?oc=5","date":"2025-02-25","type":"deal","source":"Reuters","summary":"Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion - Reuters","headline":"Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion","sentiment":"neutral"}],"patents":[{"drugName":"Solventum's Flagship Product","drugSlug":"generic-name","patentNumber":"","type":"Patent Cliff","expiryDate":"2028-06-01","territory":"US","annualRevenue":1200000000}],"drugCount":6,"phaseCounts":{"marketed":4,"phase_3":2},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":["Company1","Company2","Company3"],"therapeuticFocus":["Cardiovascular","Neurology"],"financials":{"source":"sec_edgar","revenue":8325000000,"revenuePeriod":"2025-12-31","revenueHistory":[{"value":8325000000,"period":"2025-12-31"},{"value":8254000000,"period":"2024-12-31"},{"value":8254000000,"period":"2024-12-31"},{"value":8197000000,"period":"2023-12-31"},{"value":8197000000,"period":"2023-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":739000000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":1556000000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":14294000000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"ciks":null,"lastFiledAt":null},"yahoo":{"currentPrice":64.96,"previousClose":62.49,"fiftyTwoWeekHigh":88.2,"fiftyTwoWeekLow":60.7,"fiftyTwoWeekRange":"60.7 - 88.2","fiftyDayAverage":71.55,"twoHundredDayAverage":74.55,"beta":0.77,"enterpriseValue":15211578368,"forwardPE":9.2,"priceToBook":2.23,"priceToSales":1.35,"enterpriseToRevenue":1.83,"enterpriseToEbitda":13.05,"pegRatio":1.22,"ebitda":1166000000,"ebitdaMargin":14,"freeCashflow":633249984,"operatingCashflow":369000000,"totalDebt":5248000000,"debtToEquity":103.9,"currentRatio":1.23,"returnOnAssets":2.9,"returnOnEquity":38.9,"analystRating":"2.5 - Buy","recommendationKey":"buy","numberOfAnalysts":12,"targetMeanPrice":86.58,"targetHighPrice":105,"targetLowPrice":60,"dividendRate":0,"payoutRatio":0,"fiveYearAvgDividendYield":0,"exDividendDate":0,"insiderHeldPercent":15,"institutionHeldPercent":73.7,"sharesOutstanding":173405254,"floatShares":147325055,"sharesShort":3967922,"shortRatio":2.91,"shortPercentOfFloat":2.3,"epsTrailing":8.88,"epsForward":7.04,"revenuePerShare":47.82,"bookValue":29.1,"officers":[{"age":57,"name":"Mr. Bryan C. Hanson","title":"CEO & Director"},{"age":54,"name":"Mr. Wayde D. McMillan","title":"Executive VP & CFO"},{"age":49,"name":"Ms. Amy  Landucci","title":"Chief Information & Digital Officer"},{"age":57,"name":"Ms. Marcela A. Kirberger","title":"Chief Corporate & Legal Affairs Officer & Corporate Secretary"},{"age":53,"name":"Ms. Heather L. Knight","title":"Chief Commercial Officer"},{"age":60,"name":"Ms. Mary T. Wilcox","title":"Senior VP, Corporate Controller & Chief Accounting Officer"},{"age":null,"name":"Ms. Amy  Wakeham","title":"Senior Vice President of Investor Relations & External Finance Communications"},{"age":null,"name":"Ms. Kate  Dobbs","title":"Chief Communications & Corporate Marketing Officer"}],"industry":"Medical Instruments & Supplies","irWebsite":"","website":"https://www.solventum.com","phone":""}}